Erica Jonlin / Young Lab
Erica Jonlin / Young Lab
Erica Jonlin, PhD ISCRM Regulatory Manager "What does the donor of the specimen that became WTC-11 know about your research? (And other issues you might like to know about donors […]
Dr. Phil Horner, Ph.D., Associate Professor of Neurological Surgery at the UW, is working on a unique approach to restoring limb function after chronic spinal cord injury. Dr. Horner and […] Read More
Findings bring stem cell therapy for damaged hearts closer to clinical trials In a major advance, researchers at the University of Washington have successfully restored damaged heart muscle of monkeys […] Read More
Phil Horner, PhD, Associate Professor of Neurological Surgery at the UW, is working on a unique approach to restoring limb function after chronic spinal cord injury. Dr. Horner and his […] Read More
Dr. Tony Blau, ISCRM’s Co-Director, recently presented a talk at TEDxTacoma focused on his Center for Cancer Innovation. A transcript of the video can be found here. Read More
Findings advance efforts to reprogram mature cells for organ repair Two proteins that control how cells break down glucose play a key role in forming human stem cells, University of […] Read More
These cells appear at the earliest stages of an embryo and can form all human cell types University of Washington researchers have created a line of human embryonic stem cells […] Read More
Trial enrollees sought; effort involves sharing tumors’ responses to therapy in massive public online database. Ten women with advanced breast cancer will participate in one of the most intensive clinical trials ever […] Read More
Five million Americans are living with heart disease, heart failure and 715,000 will have a heart attack this year. Now researchers at the University of Washington are working on a […] Read More
NIH, FDA policies appear to make most federally funded embryonic stem cell lines unsuitable for clinical use Since the discovery of human embryonic stem cells, scientists have had high hopes […] Read More
January 22, 2014 Preclinical studies show that gene therapy can improve muscle strength in small- and large-animal models of a fatal congenital childhood disease know as X-linked myotubular myopathy. The […] Read More